BUSINESS BENEFITS FOR 2015:• LISTEN to keynote addresses from the leaders in human
factors engineering with expert input on reachingcertain patient populations, considerations andcompliance in device design and how can we ensurethe drug product is administered safely and effectively
• LEARN about the critical issues surrounding safetyassessments of pre-filled syringes from extractablesand leachables to sterility and needle stick preventionrequirements – NEW FOR 2015
• ENHANCE your understanding of labelling and pricingconsiderations with the competitive market forbiosimilars set to storm with patent expiries due
• ASSESS the future of pre-filled syringes with case studyled presentations addressing the challenges facedwith parenteral packaging innovations and reviewingthe strategies needed to overcome the hurdles withimportance insights into autoinjectors and pens
• ADDRESS the use of lyophilisation in pre-filled syringes, isthis the future vision?
SMi presents its 2nd annual conference and exhibition on...
PLUS TWO INTERACTIVE HALF-DAY POST-CONFERENCE WORKSHOPSWednesday 29th April 2015, Renaissance Woodbridge Hotel, Iselin, New Jersey, USA
27 - 28
APRIL2015
Assessing the future of pre-filled syringes to improve innovation and device development
Renaissance Woodbridge Hotel, Iselin, New Jersey, USA
Pre-Filled SyringesAmerica
www.pfsamericas.com BOOK BY 19TH DECEMBER AND SAVE $400 • BOOK BY 30TH JANUARY AND SAVE $200
BOOK BY 27TH FEBRUARY AND SAVE $100
Register online or call +448709090711 to speak to an account executive
Sponsored by
"Excellent, informative and good quality" Delegate 2014
Advanced Delivery Systems to Enable Personalised Medicines
Workshop Leaders: Ravi S. Harapanhalli, Vice President, ParExel andMr. Sall, Principal Consultant, ParExel
8.30am – 12.30pm
Will Drug Delivery in Coming Days be an Integral Part of DDM?- Diagnose, Deliver and Monitor
Workshop Leaders: Chanderkanth Gautham, Domain Lead of Medical Device Team,Beroe Inc. and Saikrishna Garrepalli, Procurement Management Representative,
Beroe Inc.1.30pm – 5.30pm
CHAIRS FOR 2015: Ravi Harapanhalli, Vice President, ParExel
William Beierschmitt, Research Fellow, Drug Safety Research and Development, Pfizer Inc.
KEY SPEAKERS FOR 2015:• Natalia Mazaeva, Usability Leader, Sanofi • Stephen Barat, Executive Director, Forest Laboratories,
a subsidiary of Actavis • Ed Israelski, Director of Human Factors, AbbVie• Scott Brown, Device Development Lead, Merck• Li-Chun Tsou, Global Device Technical Director,
AstraZeneca Pharmaceuticals• Kiran Singh, Associate Director, Sandoz• Michel Mikhail, Former Chief Regulatory Officer,
Executive Vice President, Global Regulatory -Governmental Relations, Fresenius Kabi NV/SA
• Mark Tsai, Principal Engineer, Drug Delivery, JanssenPharmaceuticals
Plus many more...
BOOK BY 19THDECEMBER TORECEIVE OUR
SPECIAL $999 RATEFOR PHARMA
COMPANIES ONLY!
BOOK B
Y
19TH
DEC
EMBE
R
AND SAVE $
400
BOOK B
Y 30T
H JANUARY
AND SAVE $
200
BOOK B
Y 27T
H FEBR
UARY
AND SAVE $
100
@SMIPHARM#USAPFSSMI
Pharmaceutical industry’s perspectives:• Drug stability (minimize drug-syringe interactions by
mitigating leachables and extractables, flakes (lamellae)or deposits, glass fragments, and lubricant particles)
• Syringe durability• Cost
Manufacturer’s perspectives:• Simplified manufacturing/assembly processes to mitigate
batch variances• Consider stringent sterilization and packaging processes• Compliance of the mandatory "safety" PFS
Healthcare industry’s perspectives:• Avoid needlestick injuries• User-friendly• Eco-friendly (minimum residual of medicine,
recyclable device material)
Patient's perspectives:• User-friendly (convenience and safety in preparation
and self-administration)• Eco-friendly (minimum residual of medicine,
recyclable device material)• Price-friendly
Pre-Filled Syringes America Day One | Monday 27th April 2015
8.30 Registration & Coffee
9.00 Chair’s Opening RemarksWilliam Beierschmitt, Research Fellow, Drug Safety Research andDevelopment, Pfizer Inc.
HUMAN FACTOR STUDIES
OPENING ADDRESS9.10 The importance of the patient and how each individual differs
• Reviewing the patient populations and the needs of certainindividuals in device design
• How can we enhance products to ensure they’re specifically designed for the patient’s needs?
• Evaluating the best outcome for the patients, what factors should be considered
Ed Israelski, Director of Human Factors, AbbVie
9.50 Success Criteria – How can the FDA’s requirements be met? • Demonstrating safety and effectiveness in the hands of the user• Reviewing the design requirements for validation purposes• Are the customer requirements being met in design transfer? • Post –market surveillance – What observations can
be made? Natalia Mazaeva, Sr. Usability Leader, Global Usability and Risk Management, Device Development, Sanofi
CASE STUDY 10.30 End user needs and perspectives for device assembly
End User Needs and Perspectives are critical for final devicedelivery. This presentation will address the injectable devicetrends and flexibility required for an assembly machine to adaptto new market challenges while incorporating the ‘HumanFactor’. This presentation will also focus on recent Regulatoryupdates (11608) for Combination ProductsThe lecture will show:• Injectable Device Trends • Human Factor - Increased focus on safety, usability and
handling studies • Flexible standardized platforms to handle customized
assembly of pens and auto-injectors• Gentle handling of the filled glass container during
assembly of the device using proven liquid fill finish handling technology
Dena Flamm, Product Manager, Robert Bosch GmbH
11.10 Morning Coffee
KEYNOTE ADDRESS11.40 Convenience and compliance: empower the user
through good design• Reducing concerns by the end user is critical, what steps can
be taken to increase patient satisfaction?• Precision and safety go hand in hand, let’s address
considerations to ensure the product designed is safe andeffective
• How do we ensure the patient receives the exact dose intended?
Ben Bartfeld, Human Factors and Industrial Design Consultant, Otsuka Pharmaceutical Companies
12.20 What makes a pre-filled syringes ergonomic?• Addressing the importance of human factor studies
in device development• Assessing the possibilities to ensure the drug product
is administered safely and effectively • Working with clients concentrating on the design
based strategies Saikrishna Garrepalli, Procurement Management Representative, Beroe Inc.
1.00 BREAKOUT SESSION & OPPORTUNTY TO NETWORK PRE-LUNCH• Are we seeing a growing trend in drug delivery being
administered outside traditional medical settings? • How can we ensure this is safe?Host: William Beierschmitt, Research Fellow, Drug Safety Research and Development, Pfizer Inc.
1.30 Networking Lunch
CRITICAL ISSUES: SAFETY ASSESSMENT
2.40 Safety Evaluation of Leachables for Pre-Filled Syringe Drug Products • Background on leachables and pre-filled syringes• Why safety assessment for leachables is necessary• How to approach and conduct a leachable safety
evaluation• Current best practice recommendations and
examplesStephen Barat, Executive Director, Forest Laboratories, a subsidiary of Actavis
3.20 The Risk Assessment of Extractables - A Toxicological Window ofOpportunity• Ensuring compatibility of the profile of the pre-filled syringe with
the biologic• Avoiding changes in product quality• Material selection and final assessment of leachablesWilliam Beierschmitt, Research Fellow, Drug Safety Research and Development, Pfizer Inc.
4.00 Afternoon Tea
4.30 CASE STUDYIdentifying incompatibility causes and challenges • Assessing drug delivery studies and reflecting on the
impact of incompatibility
• Assessing the specific fit of LAV valves and specific issues surrounding prefilled syringe design
Kiran Singh, Associate Director, Sandoz GmbH
5.10 Assessing the safety of needle devices • Looking at the global demand of safety needle
devices• What necessary steps should be taken to ensure
a successful safety pre-filled syringe• Creative design of safety pre-filled syringesPei-Yang Phillip Hsu, Chief Executive Officer, SaferMedTechnologies Co. Ltd.
5.50 ROUND TABLE DISCUSSION AND NETWORKING OPPORTUNITY• Discussing the safety challenges surrounding pre-filled
syringesHost: Pei-Yang Phillip Hsu, Chief Executive Officer, SaferMed Technologies Co. Ltd
6.30 Chair's Closing Remarks and Close of Day One
NEW FOR2015!
NEW FOR2015!
Register online at: www.pfsamericas.com • Alternatively fax yo
Pre-Filled Syringes AmericaDay Two | Tuesday 28th April 2015
8.30 Registration & Coffee
9.00 Chair’s Opening RemarksRavi S. Harapanhalli, Vice President, ParExel
ENHANCING DEVICE DEVELOPMENT
OPENING ADDRESS9.10 Getting to market: Regulatory perspective
• Defining a pre-filled syringe as a product or device and its impact on regulatory approval
• Insight into the FDA’s current thoughtsRavi S. Harapanhalli, Vice President, ParExel,former FDA Senior Executive
9.50 Biosimilars and Delivery Devices…here we go! • Patent expiries for biologics are creating a new
competitive market for biosimilars in particular Monoclonal antibodies
• How to differentiate from the innovator with a device • Factors to Review: e.g. Interchangeability studiesMichel Mikhail, Former Chief Regulatory Officer, Executive Vice President, Global Regulatory- Governmental Relations, Fresenius Kabi NV/SA
10.30 Morning Coffee
CASE STUDY 11.00 The partnership reviewed between a pharmaceutical company
and the manufacturer/supplier• Overview of the relationship and how it was managed•An explanation on why the products have been developed
Shun Ogawa, Research Manager, Mitsubishi Gas Chemical Company, Inc.
11.40 Combination Product Considerations- Starting with the End in Mind• Evolving trends for the pre-filled syringe and self-injection markets• Industry/Supplier partnership is key to successful development
outcomes• Patient considerations and building strong product brands
through innovationRoyce Brockett, Senior Product Manager, West PharmaceuticalServices, Inc.
ROUND TABLE DISCUSSION12.20 The partnership reviewed between a pharmaceutical
company and the manufacturer/supplier• Choosing a partner: What are the decision criteria?• Who owns what: Equipment, IP, regulatory
requirements?• Managing the partnershipScott Brown, Executive Director/ Device Development Lead, Merck Research Laboratories
1.00 Networking Lunch
KEYNOTE ADDRESS2.00 Parenteral Device Strategy for Patient-Centric
Therapeutics• Advantages and Constraints of Pre-filled Syringes in Designing
Cutting Edge Devices• Global Design Control Process in Meeting Country
Specific Regulatory Expectations• Concurrent Engineering Commercialization Model
in Achieving Successful New Product Launch Li-Chun Tsou, Global Device Technical Director, AstraZeneca Pharmaceuticals
2.40 Product Line Management, sustaining activities• Engineering change plan• Product enhancement, material change, CAPA• Post market risk management• Design control, sustaining activitiesMark Tsai, Principal Engineer, Cell Therapy, Janssen R&D
3.20 BREAKOUT SESSION & OPPORTUNTY TO NETWORK• Glass v Plastic • The advantages and disadvantages• Is once still more favourable, if so why? Discuss Host: Ravi Harapanhalli, Vice President, ParExel
4.00 Afternoon Tea
CASE STUDY 4.30 Process Development studies to optimize process
parameters and finalize presentation formatCase studies included:• Development study to evaluate hold times on the
filing line • Stopper movement studies to evaluate effect of
headspaceAarti Gidh, Senior Scientific Investigator, GlaxoSmithKline
5.10 Electronics and Mobile Apps role in drug delivery and dosage adherence• How electronics and mobile apps in device development are
going to affect dosage areas in the medical device space • Some of major development in patch front which has circuitry
embedment and other innovative add on• Increasing penetration of electronics in drug delivery• Vision of leading device manufacturers and their take on
electronics future• Role of mobile apps in complimenting the growth of
electronics in device arenaChanderkanth Gautam, Domain Lead and Medical Device Community Leader, Beroe Inc.
5.50 Chairman’s Closing Remarks and Close of Day Two
Official PlatinumMedia Partner
NEW FOR2015!
NEW FOR2015!
NEW FOR2015!
Supported by
ur registration to +44 (0)870 9090 712 or call +44 (0)870 9090 711
PHARMA• What worked
(Existing Actions)Pharma companiessometimes use mono-layer plastic containersto prevent the belowproblems, but all ofthem don’t haveenough oxygen barrier.
• What could’ve beenimproved? (Existing Problems forGlass Container - Breakage- Heavy Weight- Difficulty of disposal - Protein Adsorption- Inorganic Extractable,
etc.• Moving forward, what
would you have donedifferently? (Future actions)Some antioxidizingagent might be used forinjectable drugs.
SUPPLIER• What worked
(Existing solutions bysuppliers) Some supplies providemono-layer plasticcontainers instead ofglass, but all of themdon’t have enoughoxygen barrier.
• What could’ve beenimproved?- Oxygen Barrier
• Moving forward, whatwould you have donedifferently? (Our solutions)- We developed an
oxygen absorbingpolymer.
- We also developed 3layers-containers- The oxygen absorbing
polymer is used for the middle layer
- COP which is well-known as a high moisture
HALF-DAY POST CONFERENCE WORKSHOP AMWednesday 29th April 2015 | 8.30am – 12.30pm | Renaissance Woodbridge Hotel, Iselin, New Jersey, USA
Advanced Delivery Systems to Enable Personalised Medicines
Workshop Leaders: Ravi S. Harapanhalli, Vice President, ParExel andMr. Sall, Principal Consultant, ParExel
Workshop overview:Run by one of the US’s leading figures in regulatory approval processesand drug delivery systems, Dr. Ravi Harapanhalli. This industry leadingworkshop will help you plan for smooth regulatory approvals and help withavoiding pitfalls that can cause expensive delays in taking your product tomarket.
Who should attend this workshop: R&D Scientists, Regulatory Affairs, Device specialists, Formulators,Business Development Staff
HALF-DAY POST CONFERENCE WORKSHOP PMWednesday 29th April 2015 | 1.30pm – 5.30pm | Renaissance Woodbridge Hotel, Iselin, New Jersey, USA
Will Drug Delivery in Coming Days be an Integral Part of DDM?- Diagnose, Deliver and Monitor
Workshop Leaders: Chanderkanth Gautham, Domain Lead of Medical Device Team, Beroe Inc. andSaikrishna Garrepalli, Procurement Management Representative, Beroe Inc.
Overview of workshop: Drug delivery device market would no longer exist as standalone entity. Ashealthcare longs to address all the solution through single gateway,technologies such electronic bandage, artificial pancreas pave their wayinto the market. They provide a holistic solution by diagnostic, delivering andmonitoring. This is likely to be future of healthcare.
Why you should attend this workshop:• To understand the platform that will be face of healthcare in coming days.• To understand how fast are new technologies are advancing in the space of
Medtech, and how considerable these devices were in addressing the gap thecurrently prevails will be the focus of the workshop.
About the workshop hosts:Chanderkanth Gautham A Medical Device ProcurementManagement Representative (Sr. Research Analyst) withexperiences in R&D, Human Factors, Contract Research Servicesfacilitating Medical Devices, Pharmaceutical, Cosmetics andHerbal Companies with Product development, Regulatory andPost Marketing (Medical Affairs) and Business Development
support activities across global regions.
Saikrishna Garrepalli Procurement Management Representative(Sr. Research Analyst) of leading medical device companies, Saihas experience in R&D, Human Factors, Contract ResearchServices and regulatory pathways. Currently he is analyst atMedical device team at Beroe handles various client initiativessuch as supplier relationship, negotiations and others.
About Beroe Inc. Beroe is procurement pioneer which addresses USD 15 Billion+ spend of itsclients globally. It carefully monitors the market for any sort of trend atsupplier or buyers end. And is very instrumental in benchmarking marketsand supplier capabilities across various facets of value chain ranging fromdesign to manufacturing. beroeinc.com
Programme8.30 Registration & Coffee
9.00 Introductions and Opening Remarks
9.45 Session 1: Quality-by-Design in the development of drug delivery systems
10.30 Session 2: Regulatory pitfalls to avoid
11.00 Coffee break
11.30 Session 3: New combination product regulations and how to comply with them
12.00 Session 4: How to accelerate approval through FDA
12.30 End of Workshop
Why you should attend this workshop:• Accelerate the time it takes to
take your drug delivery system tomarket
• Find out how to navigate newcombination product guidelines
• Assess the right time to start thinkingabout your drug deliverymechanism
• Develop a strategy for product lifecycle management by switchingover to PFS
• Understand how to apply the FDAQuality SystemRegulation todelivery device development
• Know how to apply FDA DesignControls to delivery devicedevelopment
• Get to appreciate how to selectionof a delivery device developmentpartner
• Perform risk analysis and HumanFactors assessment
About the workshop host: Dr. Ravi Harapanhalli advises bio/pharmaceutical companies onCMC regulatory strategies and Quality-by-Design approaches tomedicinal product development and flexible regulatoryapproaches.
About the workshop co-leader:Mr. Sall is a Principal Consultant with PAREXEL Consulting inWaltham, MA. PAREXEL provides clinical trial, clinical datamanagement, medical and regulatory services to thepharmaceutical and medical device industries.
About ParExel:Over the past 30 years, ParExel has developed significant expertise toassist clients in the worldwide pharmaceutical, biotechnology andmedical device industries with the development and launch of theirproducts in order to bring safe and effective treatments to the globalmarketplace for the patients who need them. Headquartered nearBoston, Massachusetts, ParExel operates over 77 locations throughoutmore than 51 countries around the world, and has over 14,400employees. www.parexel.com
Programme1.30 Registration and Coffee
2.00 Will drug delivery in coming days be integral part of DDM <diagnose, deliver and monitor>
Areas Covered• Introduction on these developments• Some case studies indicating the inception of the trend• Will developments in non-invasive sensor based
technologies and automatic modes of delivery increaseinclination of patients and physicians to home caretechnologies.
• Do acquisition of monitoring device companies byMedtech giants’ indicate bigger role of DDM platformsin future?
3.30 Coffee Break
4.00 Will artificial pancreas penetration in market pave way fornon-conventional diabetic therapy?Areas to be covered• Will the aforementioned platform challenge the
conventional, glucose measurement and injectiontherapy to a significant amount?
• Does this mean that conventional modes insulin deliveryvia auto injectors, pen injectors now needs a massivescale up technology wise?
• Who are those technology pioneers that need specialmention on their recent developments in same space?
5.30 End of Workshop
SPONSORED BY:
SPONSORSHIP AND EXHIBITION OPPORTUNITIESSMi offer sponsorship, exhibition, advertising and branding packages, uniquelytailored to complement your company’s marketing strategy. Prime networking
opportunities exist to entertain, enhance and expand your client base within thecontext of an independent discussion specific to your industry.
Should you wish to join the increasing number of companies benefiting fromsponsoring our conferences please call: Alia Malick on +44 (0) 20 7827 6168 or
email: [email protected]
Pre-Filled Syringes Americas
Bosch Packaging Technology is the world leader in the design and manufacture of pharmaceuticalprocessing and packaging systems. Bosch offers a range of syringe filling systems in both nested andbulk styles of systems. Bosch also now offers syringe pen assembly systems and single use dosingsystems with scalable solutions. With Bosch one supplier solutions are a real possibility.www.boschpackaging.com
JOT Automation is driven by a passion to develop and manufacture test and production solutions formobile devices, components and electronics. JOT Automation offers product platforms to solveversatile volume manufacturing challenges in the most cost-effective manner. The company is aglobal partner for several industry leading companies in the telecom, automotive and life scienceindustries. www.jotautomation.com
Mitsubishi Gas Chemical (MGC) is well-known as an expert in unique polymers and oxygen absorbers.Based on our experience and expertise, MGC has successfully developed multilayer plastic vial andsyringe with oxygen absorbing function. MGC believes they will be an only solution to replace glasswith plastic. www.mgc.co.jp/eng
West works side by side with its healthcare partners from concept to the patient, designing andmanufacturing packaging, diagnostic and delivery systems that promote the efficiency, reliabilityand safety of their products. Every day, West is leading the way with cutting-edge technologies andquality systems, a thorough understanding of global regulatory compliance, and an unmatched andgrowing knowledge base of relevant pharmaceutical product testing, development and packaging. Based in Exton, Pa., West supports its customers from sales, manufacturing, customer support andresearch and development locations in North and South America, Europe, Asia and Australia.www.westpharma.com
Want to know how you can get involved?
Interested in promoting yourservices to this market?
Contact Julia Rotar, SMi Marketingon +44 (0) 207 827 6088, or email:
WHO SHOULD ATTEND:
Those involved in the following:
• Pharma Development• Engineering• Manufacturing
Technology• Biopharma Operations• Regulatory Affairs• Parenterals
• Packaging• Formulation Aseptic• Device Development• Device Design• Labelling• Manufacturing• Drug Delivery
• Formulation & AsepticFilling Technologies
• Chemistry Manufacture Controls (CMC)
• Quality Assurance• Safe Medication
Practice
11
2 BREAKOUT SESSIONS
4 CASE STUDIESLEADING PHARMACOMPANIES SPEAKING
2 KEYNOTE ADDRESSES
100+ ATTENDEES
2 ROUND TABLE DISCUSSIONS
Attendee by Location
USA 71%
Europe 17%
India 5%
Canada 7%
KEY HIGHLIGHTS:
FAX your booking form to +44 (0) 870 9090 712PHONE on +44 (0) 870 9090 711
POST your booking form to: Events Team, SMi Group Ltd, 2nd FloorSouth, Harling House, 47-51 Great Suffolk Street, London, SE1 0BS, UK
PRE-FILLED SYRINGES AMERICA Conference: Monday 27th & Tuesday 28th April 2015, Renaissance Woodbridge Hotel, Iselin, New Jersey, USA Workshops: Wednesday 29th April 2015, USA
4 WAYS TO REGISTERwww.pfsamericas.com
If you have any further queries please call the Events Team on tel +44 (0) 870 9090 711 or you can email [email protected]
Payment: If payment is not made at the time of booking, then an invoice will be issued and must bepaid immediately and prior to the start of the event. If payment has not been received then creditcard details will be requested and payment taken before entry to the event. Bookings within 7 daysof event require payment on booking. Access to the Document Portal will not be given until paymenthas been received.Substitutions/Name Changes: If you are unable to attend you may nominate, in writing, anotherdelegate to take your place at any time prior to the start of the event. Two or more delegates maynot ‘share’ a place at an event. Please make separate bookings for each delegate.Cancellation: If you wish to cancel your attendance at an event and you are unable to send asubstitute, then we will refund/credit 50% of the due fee less a £50 administration charge, providingthat cancellation is made in writing and received at least 28 days prior to the start of the event.Regretfully cancellation after this time cannot be accepted. We will however provide theconferences documentation via the Document Portal to any delegate who has paid but is unableto attend for any reason. Due to the interactive nature of the Briefings we are not normally able toprovide documentation in these circumstances. We cannot accept cancellations of orders placedfor Documentation or the Document Portal as these are reproduced specifically to order. If we haveto cancel the event for any reason, then we will make a full refund immediately, but disclaim anyfurther liability.Alterations: It may become necessary for us to make alterations to the content, speakers, timing,venue or date of the event compared to the advertised programme.Data Protection: The SMi Group gathers personal data in accordance with the UK Data ProtectionAct 1998 and we may use this to contact you by telephone, fax, post or email to tell you about otherproducts and services. Unless you tick here □ we may also share your data with third parties offeringcomplementary products or services. If you have any queries or want to update any of the data thatwe hold then please contact our Database Manager [email protected] or visitour website www.smi-online.co.uk/updates quoting the URN as detailed above your address on theattached letter.
Unique Reference Number
Our Reference LVP-141
Terms and Conditions of Booking
DELEGATE DETAILSPlease complete fully and clearly in capital letters. Please photocopy for additional delegates.
Title: Forename:
Surname:
Job Title:
Department/Division:
Company/Organisation:
Email:
Company VAT Number:
Address:
Town/City:
Post/Zip Code: Country:
Direct Tel: Direct Fax:
Mobile:
Switchboard:
Signature: Date:I agree to be bound by SMi's Terms and Conditions of Booking.
ACCOUNTS DEPT
Title: Forename:
Surname:
Email:
Address (if different from above):
Town/City:
Post/Zip Code: Country:
Direct Tel: Direct Fax:
VENUE Renaissance Woodbridge Hotel, Iselin, New Jersey, USA
□ Please contact me to book my hotelAlternatively call us on +44 (0) 870 9090 711, email: [email protected] or fax +44 (0) 870 9090 712
EARLY BIRDDISCOUNT
Payment must be made to SMi Group Ltd, and received before the event, by one ofthe following methods quoting reference P-141 and the delegate’s name. Bookingsmade within 7 days of the event require payment on booking, methods of paymentare below. Please indicate method of payment:
A/C Name SMI GROUP LTD Sort Code 300009,Account Number 11775391 CCY USD□ Wire Transfer Lloyds TSB Bank plc, 39 Threadneedle Street, London, EC2R 8AUIBAN GB75LOYD30000911775391BIC LOYDGB21013□ Cheque We can only accept cheques in US Dollars.□ Credit Card □ Visa □ MasterCard □ American Express All credit card payments will be subject to standard credit card charges.
Card No: □□□□ □□□□ □□□□ □□□□Valid From □□/□□ Expiry Date □□/□□CVV Number □□□□ 3 digit security on reverse of card, 4 digits for AMEX card
Cardholder’s Name:
Signature: Date:I agree to be bound by SMi's Terms and Conditions of Booking.
Card Billing Address (If different from above):
DOCUMENTATIONI cannot attend but would like to purchase access to the following DocumentPortal/paper copy documentation Price Total□ Access to the conference documentation
on the Document Portal £499.00 + VAT £598.80□ The Conference Presentations – paper copy £499.00 - £499.00
(or only £300 if ordered with the Document Portal)
PAYMENT
VATVAT at 20% is charged on Document Portal and literature distribution for all UK customers andfor those EU Customers not supplying a registration number for their own country here.
______________________________________________________________________________________________
CONFERENCE PRICESI would like to attend: (Please tick as appropriate) Fee
□ Conference & 2 Workshops $2997.00□ Conference & 1 Workshop AM □ PM □ $2398.00□ Conference only $1799.00□ 2 Workshops only $1198.00□ 1 Workshop only AM □ PM □ $599.00First 25 Pharmaceutical Companies to register□ Conference & 2 Workshops $2597.00□ Conference & 1 Workshop AM □ PM □ $1998.00□ Conference only $1399.00□ 2 Workshops only $1198.00□ 1 Workshop only AM □ PM □ $599.00
PROMOTIONAL LITERATURE DISTRIBUTION
□ Distribution of your company’s promotional literature to all conference attendees £999.00 + VAT £1198.80The conference fee includes refreshments, lunch, conference papers, and access to theDocument Portal. Presentations that are available for download will be subject todistribution rights by speakers. Please note that some presentations may not be availablefor download. Access information for the document portal will be sent to the e-mailaddress provided during registration. Details are sent within 24 hours post conference.
□ Book by 19th December 2014 to receive $400 off the conference price □ Book by 30th January 2015 to receive $200 off the conference price□ Book by 27th February 2015 to receive $100 off the conference price
Top Related